Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

AcademySystematic Review

Q&A

Systematic Review Q&A: Technical Answers on Grey Literature, PRISMA-S, the Review Process and the EU HTA Regulation

Seventeen questions researchers and HTA teams ask about trial registers, search reporting, the review workflow and joint clinical assessments.

Dr. CharlieSenior Medical WriterPublishedReading time5 minutesSources5
  • Systematic review
  • PRISMA-S
  • EU HTA

At a glanceSystematic Review

PRISMA-S
16 items
Search peer review
PRESS 2015
Registers
ClinicalTrials.gov, WHO ICTRP, CTIS
JCA phases
2025, 2028, 2030

Explore systematic review servicesDiscuss your project

Quick answer

  • Search trial registers and other grey literature to reduce publication bias, and log every web search.
  • Report the search with all 16 PRISMA-S items, including full strategies as run and PRESS peer review.
  • A joint clinical assessment is an EU clinical assessment; AMNOG and national pricing decisions continue in Germany.

Overview

This page answers the questions researchers and HTA teams in Germany most often ask about a systematic review. Answers are grouped into four topics, grey literature, PRISMA-S, the review process and the EU HTA Regulation, and give the technical detail needed to act on each point.

Grey Literature

1. What counts as grey literature?

Material produced outside commercial journal publishing, such as trial registers, theses, conference abstracts, regulatory documents, HTA reports and preprints1. Our grey literature guide shows where to search by question type.

2. Why search grey literature?

To find unpublished studies and reduce the risk of publication bias, because studies with positive or significant results are more likely to be published1.

3. Which trial registers should be searched?

Commonly ClinicalTrials.gov and the WHO ICTRP and, for European trials, the EU Clinical Trials Information System (CTIS)1.

4. How should web searches be documented?

Record the site or engine, the search terms, the date, any filters and the number of results screened, and keep exports or screenshots, because web content changes2.

PRISMA-S

5. How many items does PRISMA-S have?

Sixteen, covering information sources and methods, search strategies, peer review and record management2. Our PRISMA-S checklist guide explains each item.

6. What does item 8 require?

The full search strategy for every database and source, exactly as run2.

7. Why name the database platform?

Because the same database searched through different platforms, for example MEDLINE via Ovid or via PubMed, can give different results2.

8. Which tool supports search peer review?

The PRESS 2015 guideline and checklist3; see our PRESS checklist guide.

9. How do PRISMA-S numbers link to PRISMA 2020?

Records per source and deduplication results feed the identification section of the PRISMA 2020 flow diagram24.

Systematic review support, from protocol to submission

Pubrica’s systematic review team supports protocol and PROSPERO registration, search design and PRESS peer review, grey literature searching, screening, extraction, risk of bias, synthesis and PRISMA 2020 and PRISMA-S reporting. Review authors keep ownership of and accountability for the review, and no provider can guarantee acceptance.

The Systematic Review Process

10. What are the main stages of a systematic review?

Scoping and question, protocol and registration, search strategy, searching, title and abstract screening, full-text screening, data extraction, risk of bias, synthesis and certainty of evidence, and reporting.

11. Why use two independent reviewers?

Duplicate screening and data extraction reduce errors and bias1.

12. When should a protocol be registered?

Before screening begins, for example in PROSPERO, which does not accept a review once data extraction has started. Our PROSPERO registration guide covers the steps.

13. When is narrative synthesis used instead of meta-analysis?

When studies are too different in design, populations or outcomes to pool statistically. For pooled analyses, see our meta-analysis Q&A.

The EU HTA Regulation

14. What is a joint clinical assessment?

An EU-level assessment of the relative clinical effectiveness and safety of a health technology under Regulation (EU) 2021/22825.

15. Which medicines are assessed first?

New cancer medicines and ATMPs from 12 January 2025, orphan medicines from 13 January 2028 and all medicines in the scope of the centralised procedure from 13 January 20305.

16. What is PICO scoping?

The process in which member states define the populations, interventions, comparators and outcomes the dossier must address, often several of each5.

17. Does the JCA replace AMNOG in Germany?

No. IQWiG and the G-BA still assess added benefit nationally, giving due consideration to the JCA report5. Read more in our EU HTA Regulation guide.

Pubrica team verdict

Most reviewer and HTA queries come back to one question: could someone else repeat your search and reach the same studies?

Sources

Sources were checked on 16 November 2026. Requirements and guidance may change after that date; confirm the current version with the issuing body.

  1. 1Lefebvre, C., Glanville, J., Briscoe, S., Featherstone, R., Littlewood, A., Metzendorf, M.-I., Noel-Storr, A., Paynter, R., Rader, T., Thomas, J., & Wieland, L. S. (2023). Chapter 4: Searching for and selecting studies. In J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, & V. A. Welch (Eds.), Cochrane handbook for systematic reviews of interventions (Version 6.4). Cochrane. https://training.cochrane.org/handbook/current/chapter-04
  2. 2Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., & PRISMA-S Group. (2021). PRISMA-S: An extension to the PRISMA statement for reporting literature searches in systematic reviews. Systematic Reviews, 10, Article 39. https://doi.org/10.1186/s13643-020-01542-z
  3. 3McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. Journal of Clinical Epidemiology, 75, 40–46. https://doi.org/10.1016/j.jclinepi.2016.01.021
  4. 4Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71
  5. 5Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU. (2021). Official Journal of the European Union, L 458, 1–32. https://eur-lex.europa.eu/eli/reg/2021/2282/oj

systematic reviewgrey literaturetrial registersPRISMA-Ssearch strategyPRESS

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation, so check its guide if it has one.

Dr. Charlie. (2026, November 16). Systematic Review Q&A: Technical Answers on Grey Literature, PRISMA-S, the Review Process and the EU HTA Regulation. Pubrica. https://pubrica.com/academy/systematic-review/systematic-review-questions-and-answers/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Next steps

Systematic review support, from protocol to submission

Pubrica’s systematic review team supports protocol and PROSPERO registration, search design and PRESS peer review, grey literature searching, screening, extraction, risk of bias, synthesis and PRISMA 2020 and PRISMA-S reporting. Review authors keep ownership of and accountability for the review, and no provider can guarantee acceptance.

This article is general information for researchers, not legal, regulatory or funding advice. Check the current requirements of your journal, funder, ethics committee or regulator before you act on it.

More in Systematic Review

All of Academy

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.